Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study

Affiliations

• ¹ Department of Hematology, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France; Université de Paris, France; INSERM UMR 1163, Institut Imagine, Paris.
• ² Université de Paris, France; Department of Nuclear Medicine, Cochin Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris.
• ³ Cancer Research Center of Toulouse (CRCT), Team 9, INSERM UMR 1037, Toulouse.
• ⁴ Department of Hematology, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France; Université de Paris.
• ⁵ Lymphoma Academic Research Organization (LYSARC) Lymphoma Study Association Imaging, Hôpital Henri Mondor, Créteil, France; Paris Est University, Créteil.
• ⁶ Hematology Department and INSERM U1151, Institut Necker Enfants Malades, Necker University Hospital, AP-HP, Paris.
• ⁷ Lymphoma Academic Research Organization (LYSARC) Lymphoma Study Association Imaging, Hôpital Henri Mondor, Créteil.
• ⁸ Department of Hematology, Nantes University Hospital, Nantes.
• ⁹ Department of Hematology, Institut universitaire du cancer Toulouse- Oncopole, Toulouse.
• ¹⁰ Lymphoid Malignancies Unit, Hôpital Henri Mondor, Créteil.
• ¹¹ Department of Haematology, Aix-Marseille University, Marseille.
• ¹² Department of Medical Oncology, Centre Léon Bérard, Lyon.
• ¹³ Department of Haematology, Centre Hospitalier Universitaire Estaing, Clermont-Ferrand.
• ¹⁴ Department of Hematology, Centre Henri Becquerel, Rouen.
• ¹⁵ Department of Hematology, Clinique Louis Pasteur, Nancy.
• ¹⁶ Department of Hematology, Institut Gustave-Roussy, Villejuif.
• ¹⁷ Department of Hematology, CHU Besançon, Besançon.
• ¹⁸ Strasbourg University Hospital, Strasbourg, France; INSERM S-1113, Strasbourg, France; Strasbourg University, Faculty of medicine, Strasbourg.
• ¹⁹ Department of Hematology, Hôpital Saint Vincent de Paul, Lille.
• ²⁰ Department of Hematology, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris.
• ²¹ Department of Hematology, Hôpital Lyon Sud, Pierre-Bénite, France; Société francophone de greffe de moelle et de thérapie cellulaire.
• ²² Service de pathologie, Hôpital Cochin, APHP, France; Centre de recherche des Cordeliers, Sorbonne University, INSERM, Paris University.
• ²³ Société francophone de greffe de moelle et de thérapie cellulaire, France; Department of Hematology, CHRU Nancy, Hôpital Brabois; CNRS UMR 7365, Équipe 6, Biopôle de L'Université de Lorraine, Vandoeuvre-les-Nancy.
• ²⁴ Department of Hematology, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France; Université de Paris, France; Institut Cochin, INSERM U1016, Paris.
• ²⁵ Department of Hematology, University of Montpellier, Montpellier.
• ²⁶ Department of Hematology, Dijon University Hospital, Dijon, France; INSERM UMR 1231 CHU Dijon.
• ²⁷ Department of Hematology, CHU Paris-GH St-Louis Lariboisière F-Widal - Hôpital Saint-Louis, Paris.
• ²⁸ Department of Hematology, Centre Hospitalier Lyon Sud, Pierre-Bénite.
• ²⁹ Department of Hematology, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France; Université de Paris, France; Institut Cochin, INSERM U1016, Paris, France; Translational Research Centre in Onco-hematology, Faculty of Medicine, University of Geneva, 1211, Geneva 4.
• ³⁰ Department of Hematology, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France; Université de Paris. benedicte.deau-fischer@aphp.fr.